Broadcom (AVGO.US) gains 4% after beating analyst expectations in its latest earnings, reporting first-quarter revenue of $14.92 billion (vs. a $14.6 billion consensus) and projecting roughly $14.9 billion for the current quarter. AI-related spending was a key driver: management expects $4.4 billion in AI revenue this quarter, fueling investor optimism about ongoing growth in data center infrastructure. The strong results sent Broadcom shares up as much as 13% in premarket trading, reversing some of the year’s earlier losses.
Analysts across the board cited AI demand as the main tailwind for Broadcom’s semiconductor business. Morgan Stanley noted “40%+ quarter-over-quarter growth in Ethernet AI,” while JPMorgan saw “continued strong AI networking demand” that should persist throughout the year. Software revenue also exceeded expectations, at $6.7 billion (3.5% above the consensus), and total profit rose to $1.60 per share, beating estimates of $1.50.
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appEarnings Highlights
- First-Quarter Revenue: $14.92 billion, beating the consensus estimate of $14.6 billion and growing 25% year over year.
- Profit per Share: $1.60 (excluding some items), outpacing the estimated $1.50.
- Outlook for Current Quarter: Revenue projected at about $14.9 billion, above analyst forecasts.
- AI Revenues: Expected to reach $4.4 billion in the current quarter, driven by strong demand for AI-related networking and custom solutions.
- Software Division: Posted $6.7 billion in revenue—3.5% above the consensus estimate.
Market reaction
The share price is up 2% today, and in the initial reaction, gains reached as high as 13%. However, given the negative sentiment in the broader stock market, we are currently seeing a significant reduction in investor enthusiasm.
Source: xStation 5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
